Early Recognition and Intervention in Siblings at High-risk for Neurodevelopmental Disorder
ERI-SIBS
1 other identifier
interventional
48
1 country
1
Brief Summary
H1The primary goal of this intervention study is to learn if very early parent-mediated intervention in children at risk for neurodevelopmental disorders in the first year of life can be implemented in routine care, positively impacting early sensory-motor and socio-communicative developmental trajectories and reducing the developmental gap in children with signs of concern. H2: It is here postulated that early intervention with active parental involvement can reduce parental stress, as well as improve parental understanding and responsiveness to the child's communication cues. H3: An important part of our work will be analysing data about early social and joint attention behaviours in recruited children and comparing them at different time points. The hypothesis is to find early differences between groups at baseline and to detect a change before and after the intervention. For this reason, in our study design, we decided to use technologies to collect data on quantitative measures during play-structured and laboratory sessions to understand changes in developmental trajectories. H4: Given the potential role of genetic and immunological mechanisms in ASD, one of the study's secondary aims is to investigate the impact of an early intervention programme on epigenetic changes and inflammatory and immune response. After enrolment and baseline assessments (T0), children will be allocated to the three groups:
- Group 1 - Clinical Monitoring Group (CM): Siblings of TD children subjects with no signs of concern
- Group 2 - Active Monitoring Group (AM): Siblings of ASD children with no signs of concern
- Group 3 - Early Intervention Group (EI): Siblings classified as "with signs of concern" at baseline evaluation. All children will be re-evaluated after 6 months (T1) and after 12 months (T2).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 31, 2023
CompletedFirst Submitted
Initial submission to the registry
June 3, 2024
CompletedFirst Posted
Study publicly available on registry
July 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2026
July 22, 2024
May 1, 2024
3 years
June 3, 2024
July 17, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Griffiths Scales of Child Development, 3rd Edition (Griffiths-3)
Griffiths-3 is the gold standard to provide an overall measure of a child's development (0-6 years); it permits the definition of an individual profile of strengths and needs of the child across five areas: foundations of learning, language and communication, eye and hand coordination, personal-social-emotional, gross motor UNIT OF MEASURE: Developmental quotients (range 20-150, normality 85-115)
T0 (recruitment), T1 (T0 + 6 months); T2 (T0 + 12 months)
Communication and Symbolic Behaviour Scales - Infant-Toddler Checklist (CSBS-IT-C)
is a tool for developmental screening, designed to measure 7 language predictors in children 6 to 24 months of age. The questions of the checklist may be presented in an interview format with adequate explanations to clarify what is being asked. It takes about 5 to 10 minutes to complete and permits the detection of signs of concern for ASD in infants and toddlers UNIT OF MEASURE: weighted score, number: range 3-17; no concern \> 7
T0 (recruitment), T1 (T0 + 6 months); T2 (T0 + 12 months)
Early Social Communication Scale (Échelle de la Communication Sociale Précoce, Italian adaptation, ECSP-I)
the ECSP-I is a structured assessment designed to provide measures of individual differences in nonverbal communication skills in children from 3 to 30 months of age. The administration requires 15-20 min involving the presentation of approximately 23 standardised situations which provide opportunities for social communication. The ECSP-I demonstrates strong reliability and both construct and discriminant validity Unit of measure: number. Optimal and average level (mean, range 1-4).
T0 (recruitment), T1 (T0 + 6 months); T2 (T0 + 12 months)
Satisfaction Survey
Parents of children in Groups 2 and 3 will also be asked to anonymously complete a satisfaction survey (created ad hoc for this project) immediately after the intervention to assess their satisfaction with the services provided. The questionnaire takes 5 minutes to complete. unit of measure: likert scale, range 0-5
T1 (T0 + 6 months)
Secondary Outcomes (13)
Vineland Adaptive Behaviour Scales-II - Second Edition (Vineland-II)
T0 (recruitment), T1 (T0 + 6 months); T2 (T0 + 12 months)
Questionnaire Sensory Profile - Second Edition (SP-2)
T0 (recruitment), T1 (T0 + 6 months); T2 (T0 + 12 months)
McArthur-Bates questionnaire, child's first vocabulary (PVB) - gestures and words
T0 (recruitment), T1 (T0 + 6 months); T2 (T0 + 12 months)
Infant Behavior Questionnaire-Revised (IBQ-R) and Early Childhood Behavior Questionnaire (ECBQ)
T0 (recruitment); T2 (T0 + 12 months)
Autism Diagnostic Observation Schedule, Second Edition (ADOS-2)
T2 (T0 + 12 months)
- +8 more secondary outcomes
Study Arms (3)
Early Intervention Group
EXPERIMENTALASD and typical siblings with Signs of concern
Clinical Monitoring Group
NO INTERVENTIONTypical siblings with no signs of concern Children allocated to this arm will undergo to re-assessment at T1 and T2
Active monitoring Group
EXPERIMENTALASD siblings, no signs of concern
Interventions
90-minute parent-coaching session once a week for 6 months with an expert developmental therapist, supported by a child neuropsychiatrist or psychologist. A parent will always be present and actively involved in the intervention. The intervention is individualized and tailored to each child's needs and identifies with caregivers the ways to embody objectives in daily life.
90-minute session once a month for 6 months. Sessions will be performed by an expert developmental therapist, supported by a child neuropsychiatrist or psychologist. A parent will always be present and actively involved in the intervention.
Eligibility Criteria
You may qualify if:
- Age at recruitment less than or equal to 8 months.
- Sibling diagnosed with autism spectrum disorder
- Normal neurological examination
You may not qualify if:
- Focal neurological signs/symptoms or suspicion of genetic-metabolic disorders
- Genetically determined suspected or known conditions in brother/sister
- Significant familial language barrier
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fondazione Don Carlo Gnocchi Onluslead
- University of Milano Bicoccacollaborator
- Politecnico di Milanocollaborator
- Catholic University of the Sacred Heartcollaborator
- University of Turin, Italycollaborator
Study Sites (1)
Santa Maria Nascente
Milan, 20148, Italy
Related Publications (19)
Armitano-Lago C, Willoughby D, Kiefer AW. A SWOT Analysis of Portable and Low-Cost Markerless Motion Capture Systems to Assess Lower-Limb Musculoskeletal Kinematics in Sport. Front Sports Act Living. 2022 Jan 25;3:809898. doi: 10.3389/fspor.2021.809898. eCollection 2021.
PMID: 35146425BACKGROUNDBaroncelli L, Braschi C, Spolidoro M, Begenisic T, Sale A, Maffei L. Nurturing brain plasticity: impact of environmental enrichment. Cell Death Differ. 2010 Jul;17(7):1092-103. doi: 10.1038/cdd.2009.193. Epub 2009 Dec 18.
PMID: 20019745BACKGROUNDBertram J, Kruger T, Rohling HM, Jelusic A, Mansow-Model S, Schniepp R, Wuehr M, Otte K. Accuracy and repeatability of the Microsoft Azure Kinect for clinical measurement of motor function. PLoS One. 2023 Jan 26;18(1):e0279697. doi: 10.1371/journal.pone.0279697. eCollection 2023.
PMID: 36701322BACKGROUNDColombi C, Chericoni N, Bargagna S, Costanzo V, Devescovi R, Lecciso F, Pierotti C, Prosperi M, Contaldo A. Case report: Preemptive intervention for an infant with early signs of autism spectrum disorder during the first year of life. Front Psychiatry. 2023 May 3;14:1105253. doi: 10.3389/fpsyt.2023.1105253. eCollection 2023.
PMID: 37205979BACKGROUNDDi Giovanni D, Enea R, Di Micco V, Benvenuto A, Curatolo P, Emberti Gialloreti L. Using Machine Learning to Explore Shared Genetic Pathways and Possible Endophenotypes in Autism Spectrum Disorder. Genes (Basel). 2023 Jan 25;14(2):313. doi: 10.3390/genes14020313.
PMID: 36833240BACKGROUNDElsabbagh M, Bedford R, Senju A, Charman T, Pickles A, Johnson MH; BASIS Team. What you see is what you get: contextual modulation of face scanning in typical and atypical development. Soc Cogn Affect Neurosci. 2014 Apr;9(4):538-43. doi: 10.1093/scan/nst012. Epub 2013 Feb 5.
PMID: 23386743BACKGROUNDGreen J, Charman T, Pickles A, Wan MW, Elsabbagh M, Slonims V, Taylor C, McNally J, Booth R, Gliga T, Jones EJ, Harrop C, Bedford R, Johnson MH; BASIS team. Parent-mediated intervention versus no intervention for infants at high risk of autism: a parallel, single-blind, randomised trial. Lancet Psychiatry. 2015 Feb;2(2):133-40. doi: 10.1016/S2215-0366(14)00091-1. Epub 2015 Jan 28.
PMID: 26359749BACKGROUNDGreen J, Pickles A, Pasco G, Bedford R, Wan MW, Elsabbagh M, Slonims V, Gliga T, Jones E, Cheung C, Charman T, Johnson M; British Autism Study of Infant Siblings (BASIS) Team. Randomised trial of a parent-mediated intervention for infants at high risk for autism: longitudinal outcomes to age 3 years. J Child Psychol Psychiatry. 2017 Dec;58(12):1330-1340. doi: 10.1111/jcpp.12728. Epub 2017 Apr 10.
PMID: 28393350BACKGROUNDGuzzetta A, Baldini S, Bancale A, Baroncelli L, Ciucci F, Ghirri P, Putignano E, Sale A, Viegi A, Berardi N, Boldrini A, Cioni G, Maffei L. Massage accelerates brain development and the maturation of visual function. J Neurosci. 2009 May 6;29(18):6042-51. doi: 10.1523/JNEUROSCI.5548-08.2009.
PMID: 19420271BACKGROUNDHuguet G, Benabou M, Bourgeron T. The Genetics of Autism Spectrum Disorders. 2016 Apr 5. In: Sassone-Corsi P, Christen Y, editors. A Time for Metabolism and Hormones [Internet]. Cham (CH): Springer; 2016. Available from http://www.ncbi.nlm.nih.gov/books/NBK453174/
PMID: 28892342BACKGROUNDKong X, Liu J, Chien T, Batalden M, Hirsh DA. A Systematic Network of Autism Primary Care Services (SYNAPSE): A Model of Coproduction for the Management of Autism Spectrum Disorder. J Autism Dev Disord. 2020 May;50(5):1847-1853. doi: 10.1007/s10803-019-03922-4.
PMID: 30790194BACKGROUNDLord C, Brugha TS, Charman T, Cusack J, Dumas G, Frazier T, Jones EJH, Jones RM, Pickles A, State MW, Taylor JL, Veenstra-VanderWeele J. Autism spectrum disorder. Nat Rev Dis Primers. 2020 Jan 16;6(1):5. doi: 10.1038/s41572-019-0138-4.
PMID: 31949163BACKGROUNDLuyster RJ, Wagner JB, Vogel-Farley V, Tager-Flusberg H, Nelson CA 3rd. Neural correlates of familiar and unfamiliar face processing in infants at risk for autism spectrum disorders. Brain Topogr. 2011 Oct;24(3-4):220-8. doi: 10.1007/s10548-011-0176-z. Epub 2011 Mar 26.
PMID: 21442325BACKGROUNDMaenner MJ, Warren Z, Williams AR, Amoakohene E, Bakian AV, Bilder DA, Durkin MS, Fitzgerald RT, Furnier SM, Hughes MM, Ladd-Acosta CM, McArthur D, Pas ET, Salinas A, Vehorn A, Williams S, Esler A, Grzybowski A, Hall-Lande J, Nguyen RHN, Pierce K, Zahorodny W, Hudson A, Hallas L, Mancilla KC, Patrick M, Shenouda J, Sidwell K, DiRienzo M, Gutierrez J, Spivey MH, Lopez M, Pettygrove S, Schwenk YD, Washington A, Shaw KA. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020. MMWR Surveill Summ. 2023 Mar 24;72(2):1-14. doi: 10.15585/mmwr.ss7202a1.
PMID: 36952288BACKGROUNDRutherford MD, Walsh JA, Lee V. Brief Report: Infants Developing with ASD Show a Unique Developmental Pattern of Facial Feature Scanning. J Autism Dev Disord. 2015 Aug;45(8):2618-23. doi: 10.1007/s10803-015-2396-7.
PMID: 25703032BACKGROUNDSaresella M, Marventano I, Guerini FR, Mancuso R, Ceresa L, Zanzottera M, Rusconi B, Maggioni E, Tinelli C, Clerici M. An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children. Biol Psychiatry. 2009 Nov 15;66(10):978-84. doi: 10.1016/j.biopsych.2009.06.020. Epub 2009 Aug 22.
PMID: 19699471BACKGROUNDWade L, Needham L, McGuigan P, Bilzon J. Applications and limitations of current markerless motion capture methods for clinical gait biomechanics. PeerJ. 2022 Feb 25;10:e12995. doi: 10.7717/peerj.12995. eCollection 2022.
PMID: 35237469BACKGROUNDWhittingham K, McGlade A, Kulasinghe K, Mitchell AE, Heussler H, Boyd RN. ENACT (ENvironmental enrichment for infants; parenting with Acceptance and Commitment Therapy): a randomised controlled trial of an innovative intervention for infants at risk of autism spectrum disorder. BMJ Open. 2020 Aug 20;10(8):e034315. doi: 10.1136/bmjopen-2019-034315.
PMID: 32819928BACKGROUNDAnnunziata S, Purpura G, Piazza E, Meriggi P, Fassina G, Santos L, Ambrosini E, Marchetti A, Manzi F, Massaro D, Tacci AL, Bolognesi E, Agostini S, La Rosa F, Pedrocchi APG, Molina P, Cavallini A. Early Recognition and Intervention in SIBlingS at High Risk for Neurodevelopment Disorders (ERI-SIBS): a controlled trial of an innovative and ecological intervention for siblings of children with autism spectrum disorder. Front Pediatr. 2025 Jan 6;12:1467783. doi: 10.3389/fped.2024.1467783. eCollection 2024.
PMID: 39834490DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2024
First Posted
July 22, 2024
Study Start
May 31, 2023
Primary Completion (Estimated)
May 31, 2026
Study Completion (Estimated)
May 31, 2026
Last Updated
July 22, 2024
Record last verified: 2024-05